Related references
Note: Only part of the references are listed.Reduction in Revascularization With Icosapent Ethyl Insights From REDUCE-IT Revascularization Analyses
Benjamin E. Peterson et al.
CIRCULATION (2021)
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Prakriti Gaba et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
REDUCE-IT USA Results From the 3146 Patients Randomized in the United States
Deepak L. Bhatt et al.
CIRCULATION (2020)
PCSK9 Inhibition for Therapeutic Decision-Making Assessing the Value
William S. Weintraub et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes The ODYSSEY OUTCOMES Trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
Risha Gidwani et al.
PHARMACOECONOMICS (2020)
Effects of Icosapent Ethyl on Total Ischemic Events From REDUCE-IT
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The cost-effectiveness of omega-3 polyunsaturated fatty acids - The Australian healthcare perspective
Lan Gao et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy
Brian C. Case et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Risk of Total Events With Icosapent Ethyl Can We Reduce It?
Christopher B. Granger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cost-Effectiveness of Alirocumab A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial
Dhruv S. Kazi et al.
ANNALS OF INTERNAL MEDICINE (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States
Abe Dunn et al.
HEALTH SERVICES RESEARCH (2018)
In-Hospital Outcomes and Complications of Coronary Artery Bypass Grafting in the United States Between 2008 and 2012
Kasra Moazzami et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2017)
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
A. P. Bress et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia
Henry J. Henk et al.
ADVANCES IN THERAPY (2015)
Quantifying the Utility of Taking Pills for Cardiovascular Prevention
Robert Hutchins et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Cost-Effectiveness of Revascularization Strategies The ASCERT Study
Zugui Zhang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Professional Fee Ratios for US Hospital Discharge Data
Cora Peterson et al.
MEDICAL CARE (2015)
Quantifying the Utility of Taking Pills for Cardiovascular Prevention
Robert Hutchins et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey
Robert Hutchins et al.
BMJ OPEN (2015)
Probabilistic sensitivity analysis in health economics
Gianluca Baio et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2015)
Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010 The Global Burden of Disease 2010 Study
Andrew E. Moran et al.
CIRCULATION (2014)
Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
David J. Cohen et al.
CIRCULATION (2014)
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
CIRCULATION (2014)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Share Paper
